Class II recall: Apollo Care, LLC: SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcut
Apollo Care, LLC has issued a Class II recall for SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL sterile multi-dose vials for subcutaneous injection, NDC 71170-810-01. The recall notice cites presence of particulate matter, identified as nylon/polyamide and silk/proteinaceous-type material, in the product. The listing does not specify additional clinical details or the scope of distribution.
Most relevant for: Patients with diabetes or obesity receiving semaglutide treatment via subcutaneous injection
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More internal medicine updates
- Long-acting injectable noninferior to oral HIV therapy in adherence trialOct 15, 2026
- Ponatinib-Blinatumomab Beats Imatinib-Chemotherapy in Ph-Positive ALL TrialOct 15, 2026
- Isoflurane sedation does not lower mortality in hypoxemic respiratory failureOct 14, 2026
- Trial finds higher mortality with intermittent vs continuous renal-replacement therapyOct 14, 2026
- No Overall Rise in Birth Defects With Early Benzodiazepine UseOct 13, 2026